Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Stuart Schreiber on Stuart Schreiber | Main | The Vapor Trail I Referred To »

April 21, 2004

Mutter, Mutter, Mutter

Email This Entry

Posted by Derek

I spent my morning wandering through the labs with an inventory sheet in my hand, muttering about what kind of research organization this is if nobody has any triflic anhydride, damn it. For the non-chemists in the audience, this is pretty reactive stuff. It turns alcohols into trifluoromethanesulfonate esters, which nomenclature has been understandably shortened to "triflate" over the years.

We do a lot of these reactions known as nucleophilic substitutions, where one group basically comes in and kicks another one out. Some of them will only work well when you have the most reactive partner you can find, and triflate is God's own leaving group. Once your alcohol has been converted, the sulfonate ester will make way for just about anything you can toss into the flask. In many cases, you don't spend much time purifying or isolating the triflate - just wash the reaction a bit, evaporate the solvent, and roll on to the next step, which is what I was doing today.

Once I found the reagent, that is. Turns out that I was only partially a victim of bad inventory control, though. I was also feeling the effect of not working in the lab as much as I used to. They used to - back in the old days, sonny - package triflic anhydride in glass ampoules. Those are a bit of a pain, because you need to snap them open, which process either works just fine or really not fine at all. The smaller ampoules come pre-scored around their narrowed neck, but the larger ones (say, fifty grams) have to be touched up a bit first with a metal file, unless you're a real buckaroo. (As a side annoyance, this is pretty much the only use most organic chemists have for a triangular metal file, so it can be hard to track one down.)

Once you've opened the thing, you have to find a new container for the leftover reagent. Of course, if there were a good way to store the stuff in a regular container, they wouldn't ship it to you in an ampoule, now would they? Triflic anhydride, and its hydrolysis product, the viciously strong triflic acid, are notorious plastic-eaters and cap-softeners. I'd estimate that a solid majority of the stuff sold every year has gone to waste. People come back in a couple of months and find the stuff looking like used lawnmower oil, so out it goes.

Progress has been scurrying along, though, while I wasn't watching, and it turns out that they now sell the reagent in a regular bottle. The cap is made of some hardy high-density polymer, seemingly impervious to the nastiness it contains. Doubtless I looked right at some of these in the labs where I was searching, not realizing that my mental picture was now out of date. Trifluoromethanesulfonates themselves, though, never go out of style.

Comments (0) + TrackBacks (0) | Category: Life in the Drug Labs


COMMENTS

EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Academia and Industry, Suing Each Other
Let's Start Off the Meeting With An Ad, OK?
The Academic-Industrial Collaboration in Drug Discovery Panel: Today
Glass Structure, Atom by Atom
How the Andrulis Paper Got Published
AstraZeneca in Waltham
Fluorine NMR: Why Not?
AstraZeneca Layoffs and Closings